Biomedical research faces enormous challenges as the volume of genomic, transcriptomic, metabolomic, phenotypic, and other data generated in research labs across the world continues to grow. According to the National Center for Biotechnology Information, the total amount of sequence data alone is doubling every seven months. Although analyzing this staggering amount of data presents the potential […]

ALPCO recently announced its partnership with InSphero, AG to provide customers with a complete solution to assess beta-cell function in islet microtissue culture models. InSphero’s 3D InSight™ Diabetes Discovery Platform offers users a comprehensive beta-cell function application suite with all required materials to quantify insulin secretion from 3D InSight™ Islet Microtissues, including ALPCO’s validated STELLUX® Chemiluminescent Insulin ELISA. InSphero Group Head […]

LINCOLN, Neb. — LI-COR Biosciences announces an agreement with Vergent Bioscience, a cancer-focused biotechnology company, to license its IRDye QC-1 quencher technology and provide cGMP custom manufacturing services. Vergent is developing a tumor-targeted, fluorescent probe to help surgeons quickly identify and remove cancerous tissue during surgery. “LI-COR has a proven track record in developing near-infrared technologies,” says John […]

La Vista, NE – Streck, Inc. and Cromoion SRL, a distributor of human and veterinary diagnostic products in Argentina, have signed a three-year distribution agreement for Streck’s full portfolio of controls, cell stabilization and molecular products. Streck’s cell stabilization products include Cyto-Chex® BCT, a blood collection tube for the preservation of whole blood specimens for […]

BASEL, Switzerland and WALTHAM, Mass. — Enzyvant, a biopharmaceutical company focused on developing innovative treatments for people living with rare diseases, today announced that it has formed a collaboration with PerkinElmer Genomics, a global genomic testing company. PerkinElmer Genomics will leverage its network of global labs and testing platform to offer eligible providers and patients around the world […]

Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has entered into a one-year funded research collaboration with a large European consortium to further develop and validate the mechanistic Transdermal Compartmental Absorption and Transit (TCAT™) model in GastroPlus™. Dr. […]

Primary Goal is Delivery of Higher Quality, Longer Lasting Liquid Foods and Beverages  not Requiring Refrigeration or Chemical Additives   South Easton, MA — Pressure BioSciences, Inc. (OTCQB: PBIO) (“PBI” or the “Company”), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences industry, today announced a […]

PORT WASHINGTON, N.Y. — Pall Corporation, a global leader in filtration, separation and purification, is pleased to announce the extension of a consumables distribution agreement with KANEKA Corporation. In addition to flagship KANEKA KanCapA Protein A chromatography sorbents, the Pall Biotech business unit now features the company’s next generation KANEKA KanCapA 3G sorbent for the primary capture of monoclonal antibodies […]

MONTREAL’S MÉDIMABS TO DISTRIBUTE REAGENT ANTIBODIES TO INTERNATIONAL MARKET Toronto, ON, Canada – The Centre for the Commercialization of Antibodies and Biologics (CCAB) and MédiMabs Antibodies have signed an agreement for the distribution of CCAB’s reagent antibodies. The agreement marks the launch of a new business segment for CCAB and allows MédiMabs to expand its portfolio to include human synthetic […]

Combining the world-leading proteomic and artificial intelligence/machine learning technologies to produce novel, actionable health insights across many diseases, conditions and markets SomaLogic and GNS Healthcare announced today that SomaLogic has obtained a license to apply GNS Healthcare’s proprietary REFS™ (Reverse Engineering & Forward Simulation) causal machine learning technology to SomaLogic’s proprietary SOMAscan®-derived protein data sets. […]